BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2616107)

  • 1. Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism.
    Rangaswamy M; Padhy AK; Gopinath PG; Shukla NK; Gupta K; Kapoor MM
    Nucl Med Commun; 1989 Sep; 10(9):679-84. PubMed ID: 2616107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis.
    Marigold JH; Morgan AK; Earle DJ; Young AE; Croft DN
    Br J Surg; 1985 Jan; 72(1):45-7. PubMed ID: 3967130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of preoperative administration of Lugol's solution on thyroid blood flow in hyperthyroidism].
    Rodier JF; Janser JC; Petit H; Schneegans O; Ott G; Kaissling A; Grob JC; Velten M
    Ann Chir; 1998; 52(3):229-33. PubMed ID: 9752450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism.
    Chang DC; Wheeler MH; Woodcock JP; Curley I; Lazarus JR; Fung H; John R; Hall R; McGregor AM
    Surgery; 1987 Dec; 102(6):1055-61. PubMed ID: 3317958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter.
    Ansaldo GL; Pretolesi F; Varaldo E; Meola C; Minuto M; Borgonovo G; Derchi LE; Torre GC
    J Am Coll Surg; 2000 Dec; 191(6):607-12. PubMed ID: 11129808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
    Huang SM; Liao WT; Lin CF; Sun HS; Chow NH
    World J Surg; 2016 Mar; 40(3):505-9. PubMed ID: 26546192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrasonographic evaluation of thyroid tissue perfusion in patients with Graves-Basedow disease as preparation for surgery].
    Rogula T; Cichoń S
    Folia Med Cracov; 2000; 41(3-4):121-9. PubMed ID: 11339007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease.
    Erbil Y; Ozluk Y; Giriş M; Salmaslioglu A; Issever H; Barbaros U; Kapran Y; Ozarmağan S; Tezelman S
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2182-9. PubMed ID: 17389702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.
    Calissendorff J; Falhammar H
    Endocrine; 2017 Dec; 58(3):467-473. PubMed ID: 29075974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis.
    Gul K; Di Ri Koc A; Ki Yak G; Ersoy PE; Ugras NS; Ozdemi D; Ersoy R; Cakir B
    Minerva Endocrinol; 2009 Dec; 34(4):281-8. PubMed ID: 20046157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The surgical treatment of hyperthyroid goiters--the current approach and the trends].
    Ganchev G; Sechanov T; Velkov M
    Khirurgiia (Sofiia); 1994; 47(2):14-6. PubMed ID: 7884997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
    Etling N
    Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid vascularity--documentation of the iodide effect in thyrotoxicosis.
    Brownlie BE; Turner JG; Ellwood MA; Rogers TG; Armstrong DI
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):317-22. PubMed ID: 578622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of plasmapheresis on myocardial functional activity and blood circulation in the thyroid in thyrotoxicosis patients].
    Neĭmark II; Antonovich IuA
    Probl Endokrinol (Mosk); 1984; 30(4):18-21. PubMed ID: 6206490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid morphology and function after surgical treatment of thyroid diseases.
    Mann B; Schmale P; Stremmel W
    Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
    Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.